TRPV4-pathy, a novel channelopathy affecting diverse systems

被引:41
作者
Dai, Jin [2 ]
Cho, Tae-Joon [3 ]
Unger, Sheila [4 ]
Lausch, Ekkehart [4 ]
Nishimura, Gen [5 ]
Kim, Ok-Hwa [6 ]
Superti-Furga, Andrea [4 ]
Ikegawa, Shiro [1 ]
机构
[1] RIKEN, Ctr Genom Med, Lab Bone & Joint Dis, Minato Ku, Tokyo 1088639, Japan
[2] Nanjing Univ, Sch Med, Drum Tower Hosp, Ctr Diag & Treatment Joint Dis, Nanjing 210008, Peoples R China
[3] Seoul Natl Univ, Dept Orthopaed Surg, Childrens Hosp, Seoul, South Korea
[4] Univ Freiburg, Ctr Pediat & Adolescent Med, Freiburg, Germany
[5] Tokyo Metropolitan Kiyose Childrens Hosp, Dept Radiol, Kiyose, Japan
[6] Ajou Univ Hosp, Dept Radiol, Suwon, South Korea
关键词
mutation; neuropathy; skeletal dysplasia; TRPV4; TRPV4-pathy; TRPV4; GENE; MUTATIONS; DISEASE; DOMAIN;
D O I
10.1038/jhg.2010.37
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Transient receptor potential cation channel, subfamily V, member 4 (TRPV4) is a calcium-permeable nonselective cation channel of unknown biological function. TRPV4 mutation was first identified in brachyolmia, and then in a spectrum of autosomal-dominant skeletal dysplasias, which includes Kozlowski type of spondylometaphyseal dysplasia, metatropic dysplasia, Maroteaux type of spondyloepiphyseal dysplasia and parastremmatic dysplasia. Recently, TRPV4 mutation has also been identified in a spectrum of neuromuscular diseases that includes congenital distal spinal muscular atrophy (SMA), scapuloperoneal SMA, and hereditary motor and sensory neuropathy type IIC. These diverse spectrums of diseases compose a novel channelopathy, TRPV4-pathy, which could further include polygenic traits such as serum sodium concentration and a chronic obstructive pulmonary disease. In this review, we clarified the TRPV4 mutation spectrum, and discussed the phenotypic complexity of TRPV4-pathy and its pathogenic mechanisms. TRPV4-pathy may extend further to other monogenic and polygenic diseases. Journal of Human Genetics (2010) 55, 400-402; doi:10.1038/jhg.2010.37; published online 27 May 2010
引用
收藏
页码:400 / 402
页数:3
相关论文
共 13 条
[1]   Alterations in the ankyrin domain of TRPV4 cause congenital distal SMA, scapuloperoneal SMA and HMSN2C [J].
Auer-Grumbach, Michaela ;
Olschewski, Andrea ;
Papic, Lea ;
Kremer, Hannie ;
McEntagart, Meriel E. ;
Uhrig, Sabine ;
Fischer, Carina ;
Froehlich, Eleonore ;
Balint, Zoltan ;
Tang, Bi ;
Strohmaier, Heimo ;
Lochmueller, Hanns ;
Schlotter-Weigel, Beate ;
Senderek, Jan ;
Krebs, Angelika ;
Dick, Katherine J. ;
Petty, Richard ;
Longman, Cheryl ;
Anderson, Neil E. ;
Padberg, George W. ;
Schelhaas, Helenius J. ;
van Ravenswaaij-Arts, Conny M. A. ;
Pieber, Thomas R. ;
Crosby, Andrew H. ;
Guelly, Christian .
NATURE GENETICS, 2010, 42 (02) :160-U96
[2]   The C-terminal domain of TRPV4 is essential for plasma membrane localization [J].
Becker, Daniel ;
Mueller, Margarethe ;
Leuner, Kristina ;
Jendrach, Marina .
MOLECULAR MEMBRANE BIOLOGY, 2008, 25 (02) :139-U31
[3]  
DAI J, J MED GENET IN PRESS
[4]   Scapuloperoneal spinal muscular atrophy and CMT2C are allelic disorders caused by alterations in TRPV4 [J].
Deng, Han-Xiang ;
Klein, Christopher J. ;
Yan, Jianhua ;
Shi, Yong ;
Wu, Yanhong ;
Fecto, Faisal ;
Yau, Hau-Jie ;
Yang, Yi ;
Zhai, Hong ;
Siddique, Nailah ;
Hedley-Whyte, E. Tessa ;
DeLong, Robert ;
Martina, Marco ;
Dyck, Peter J. ;
Siddique, Teepu .
NATURE GENETICS, 2010, 42 (02) :165-U102
[5]   The vanilloid transient receptor potential channel TRPV4: From structure to disease [J].
Everaerts, Wouter ;
Nilius, Bernd ;
Owsianik, Grzegorz .
PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY, 2010, 103 (01) :2-17
[6]   Mutations in the Gene Encoding the Calcium-Permeable Ion Channel TRPV4 Produce Spondylometaphyseal Dysplasia, Kozlowski Type and Metatropic Dysplasia [J].
Krakow, Deborah ;
Vriens, Joris ;
Camacho, Natalia ;
Luong, Phi ;
Deixler, Hannah ;
Funari, Tara L. ;
Bacino, Carlos A. ;
Irons, Mira B. ;
Holm, Ingrid A. ;
Sadler, Laurie ;
Okenfuss, Ericka B. ;
Janssens, Annelies ;
Voets, Thomas ;
Rimoin, David L. ;
Lachman, Ralph S. ;
Nilius, Bernd ;
Cohn, Daniel H. .
AMERICAN JOURNAL OF HUMAN GENETICS, 2009, 84 (03) :307-315
[7]   Mutations in TRPV4 cause Charcot-Marie-Tooth disease type 2C [J].
Landoure, Guida ;
Zdebik, Anselm A. ;
Martinez, Tara L. ;
Burnett, Barrington G. ;
Stanescu, Horia C. ;
Inada, Hitoshi ;
Shi, Yijun ;
Taye, Addis A. ;
Kong, Lingling ;
Munns, Clare H. ;
Choo, Shelly S. ;
Phelps, Christopher B. ;
Paudel, Reema ;
Houlden, Henry ;
Ludlow, Christy L. ;
Caterina, Michael J. ;
Gaudet, Rachelle ;
Kleta, Robert ;
Fischbeck, Kenneth H. ;
Sumner, Charlotte J. .
NATURE GENETICS, 2010, 42 (02) :170-U109
[8]   Transient dimerization and interaction with ERGIC-53 occur in the fibroblast growth factor receptor 3 early secretory pathway [J].
Lievens, Patricia M-J. ;
De Servi, Barbara ;
Garofalo, Silvio ;
Lunstrum, Gregory P. ;
Horton, William A. ;
Liboi, Elio .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2008, 40 (11) :2649-2659
[9]   K644E/M FGFR3 mutants activate Erk1/2 from the endoplasmic reticulum through FRS2α and PLCγ-independent pathways [J].
Lievens, PMJ ;
Roncador, A ;
Liboi, E .
JOURNAL OF MOLECULAR BIOLOGY, 2006, 357 (03) :783-792
[10]  
NISHIMURA G, AM J MED GE IN PRESS